Blood Test Predicts Who’ll Respond to a New Lung Cancer Immunotherapy New Cancer Discovery paper reveals a liquid biopsy biomarker that may finally tell doctors which small‑cell lung cancer patients will benefit from tarlatamab. KEY FINDINGS • Scientists analyzed circulating tumor cells (CTCs) in the blood of patients with small‑cell lung cancer treated with the bispecific T‑cell engager tarlatamab. • Tumors with high DLL3 expression on CTCs correlated with strong treatment responses. • The bloo

Biomarker testing could customize treatments for cancer patients

Profiling the cell surface of cancer cell lines for biomarker/drug target discovery using MS-based proteomics

Bill would require insurer coverage for biomarker testing in Mississippi

New Podcast Launches on World Cancer Day: Addresses Gaps. Men’s Cancer Education, Biomarker Testing, & Patient Advocacy

Legislative study committee hears testimony on benefits of biomarker testing

Should I Have Biomarker Testing Done for Colorectal Cancer?

Access to Biomarker Testing